A Review of Direct-acting Oral Anticoagulants and Their Use in Solid Organ Transplantation.
Transplantation
; 106(11): 2143-2154, 2022 11 01.
Article
in English
| MEDLINE | ID: covidwho-2278350
ABSTRACT
Direct-acting oral anticoagulant (DOAC) use has increased dramatically since their introduction because of the growing evidence of proven efficacy and enhanced safety compared with warfarin and the low-molecular-weight heparins in the general population. Unfortunately, there is a dearth of quality data regarding the safety and efficacy of the DOACs in patients awaiting organ transplant and those who received a solid organ transplant. This review aims to evaluate the available literature and considerations regarding anticoagulation use in transplant recipients, focusing on preoperative, perioperative, and postoperative DOAC use.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Warfarin
/
Organ Transplantation
Type of study:
Experimental Studies
Limits:
Humans
Language:
English
Journal:
Transplantation
Year:
2022
Document Type:
Article
Affiliation country:
TP.0000000000004195
Similar
MEDLINE
...
LILACS
LIS